Effective Ebola vaccine draws closer

Early results of an Ebola vaccine efficacy trial show 100% efficacy in individuals, says the World Health Organization. Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts— the Data and Safety Monitoring Board—that conducted